Cell & Gene Therapies

CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Cell & Gene Therapies


mundoamerica.com > british > 09/21/2026 > 6ab0f2f5e9cf4aa7138b456c.html

The controversial Chinese surgery against Alzheimer's: thousands operated without clinical evidence and its creator detained

The controversial Chinese surgery against Alzheimer's: thousands operated without clinical evidence and its creator detained9+ hour, 47+ min ago   (400+ words) The cervical anastomosis technique promises to 'clean' the brain of harmful proteins. Despite being prohibited in China and lacking conclusive trials, centers around the world (including hospitals in Spain) are analyzing if there is a scientific basis behind the 'miracle…...


royalgazette.com > health > news > article > 20/26/0921 > expert-to-talk-on-new-medical-horizons-through-genetics

Expert to talk on new medical horizons through genetics

1+ hour, 48+ min ago   (218+ words) The featured speaker at a networking dinner for the island’s medical sector this week will give a talk about advances in genetics. Carika Weldon, the head and founder of CariGenetics, will discuss what genetic testing is revealing about medication safety,…...


seekingalpha.com > news > 4644970-candel-upgraded-bofa-prostate-cancer-gene-therapy

Candel upgraded at BofA on prostate cancer gene therapy (CADL:NASDAQ)

Candel upgraded at BofA on prostate cancer gene therapy (CADL:NASDAQ)5+ hour, 8+ min ago   (19+ words) BofA upgrades Candel Therapeutics to Buy, citing CAN-2409 prostate cancer gene therapy and 2027 approval odds. Read more here....


oncodaily.com > event > neoadjuvant-immunotherapy-590842

2026 ACI: A Focus on Neoadjuvant Immunotherapy - Oncology News, Insights, Stories by OncoDaily

7+ hour, 4+ min ago   (148+ words) The Big Questions in Cancer Immunotherapy: Can We Treat Toxicity Without Losing Antitumor Immunity? 10 Must-Read Posts In GU Oncology This Week 10 Must-Read Posts In GI Oncology This Week How Do Our Genes Shape Our Lung Cancer Risk? - The Mark Foundation…...


gxpnews.net > en > 2026 > 09 > russian-scientists-create-worlds-first-registered-crispr-cas-test-for-antibiotic-resistance

Russian scientists create world???s first registered CRISPR/Cas test for antibiotic resistance | News

Russian scientists create world???s first registered CRISPR/Cas test for antibiotic resistance | News8+ hour, 54+ min ago   (217+ words) Russian scientists create world’s first registered CRISPR/Cas test for antibiotic resistance Новости GxP Specialists at the Central Research Institute of Epidemiology of Rospotrebnadzor have developed a PCR test for determining antibiotic resistance, the agency’s press service reported. It is…...


nature.com > articles > d41586-026-02981-9

'Epigenetic' editing is here: gene-tagging technique banishes hepatitis B virus

'Epigenetic' editing is here: gene-tagging technique banishes hepatitis B virus9+ hour ago   (211+ words) Technique uses chemical tags to shut down viral DNA lurking in host’s genome....


bioengineer.org > dual-t-cell-activator-breathes-new-life-into-checkpoint-therapy-for-resistant-cancers

Dual T-Cell Activator Breathes New Life Into Checkpoint Therapy for

Dual T-Cell Activator Breathes New Life Into Checkpoint Therapy for17+ hour, 54+ min ago   (75+ words) Immune checkpoint inhibitors have transformed the treatment landscape for many cancers, yet a stubborn fraction of patients either never respond or relapse after an initial benefit. The central obstacle in these refractory cases is T-cell exhaustion: tumor-fighting CD8+ T cells that…...


bioengineer.org > deadly-wheat-fungus-reveals-a-hidden-molecular-switch-that-controls-its-toxin-and-spread

Deadly Wheat Fungus Reveals a Hidden Molecular Switch That Controls Its

Deadly Wheat Fungus Reveals a Hidden Molecular Switch That Controls Its18+ hour, 13+ min ago   (96+ words) Scientists have uncovered a previously hidden partnership inside one of the world’s most destructive crop pathogens, and the discovery could reshape how farmers fight a disease that devastates wheat harvests and poisons grain supplies. A research team working on Fusarium…...


bioengineer.org > second-car-t-cell-infusion-hits-myeloma-after-celmod-bridging

Second CAR T-Cell Infusion Hits Myeloma After CELMoD Bridging

Second CAR T-Cell Infusion Hits Myeloma After CELMoD Bridging18+ hour, 54+ min ago   (475+ words) A case report from German hematologists suggests that patients with advanced multiple myeloma may still benefit from a second BCMA-directed CAR T-cell therapy, even after their disease has progressed following a first such treatment....


openpr.com > news > 4636057 > car-t-clinical-trial-pipeline-gains-momentum-180-companies

CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight3+ day, 6+ hour ago   (60+ words) CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies openPR.com CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: ABNewswire Permanent link to this press release: You can edit or delete your…...